Abbott Laboratories has won expanded approval of its rheumatoid arthritis drug Humira. Humira is now approved for psoriatic arthritis and as a front-line RA therapy. The drug targets a misdirected immune response in which healthy tissue is attacked, inducing skin inflammation, swelling and pain.
- read this AP article for more